Free. Unsubscribe any time.
Regulus Therapeutics Inc. (RGLS)
Regulus Therapeutics Inc. filed 4 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 7 transactions and 245,938 shares. 4 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2025-01-15, came on the same day as the one before it (2025-01-15) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 127,054 shares, 83,419 more than the 43,635 in the filing before it.
- Its 4 filings on file run from 2025-01-15 to 2025-01-15, and state no plan adoption date.
Trades in Regulus Therapeutics Inc. 7
- Aker Christopher Ray — 2025-01-13 · S · 38,547 shares
- CALSADA CRISPINA — 2025-01-13 · S · 38,716 shares
- Hagan Joseph P — 2025-01-13 · S · 115,290 shares
- Klassen Preston — 2025-01-13 · S · 31,445 shares
- Aker Christopher Ray — 2025-01-14 · S · 5,088 shares
- CALSADA CRISPINA — 2025-01-14 · S · 5,088 shares
- Hagan Joseph P — 2025-01-14 · S · 11,764 shares
Adoption dates in Regulus Therapeutics Inc. 0
Results prints in Regulus Therapeutics Inc. 0
Trades before a print in Regulus Therapeutics Inc. 0
Interval to Regulus Therapeutics Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 7no later print
Sources: SEC EDGAR full-text search and the SEC submissions API.